ERGIC3 anticorps (C-Term)
Aperçu rapide pour ERGIC3 anticorps (C-Term) (ABIN7184887)
Antigène
Voir toutes ERGIC3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Fonction
- ERGIC3 Antibody
-
Réactivité croisée
- Souris
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the C-terminal region of Human ERGIC-3.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
-
Autre désignation
- ERGIC3
-
Sujet
- 2310015B14Rik antibody, AV318804 antibody, C20orf47 antibody, CGI 54 antibody, D2Ucla1 antibody, dJ477O4.2 antibody, DKFZp547A2190 antibody, Endoplasmic reticulum Golgi intermediate compartment protein 3 antibody, endoplasmic reticulum localized protein ERp43 antibody, Endoplasmic reticulum-Golgi intermediate compartment protein 3 antibody, ERGI3_HUMAN antibody, ERGIC and golgi 3 antibody, ergic3 antibody, ERV46 antibody, NY BR 84 antibody, PRO0989 antibody, RP23-220D12.2 antibody, RP3-477O4.1 antibody, SDBCAG84 antibody, Serologically defined breast cancer antigen 84 antibody, Serologically defined breast cancer antigen NY BR 84 antibody, Serologically defined breast cancer antigen NY-BR-84 antibody
-
UniProt
- Q9Y282
Antigène
-